| Metabolism, Catabolism & Biomolecular Synthesis |
|
| Cellular nitrogen compound metabolic process |
4.51E-132 |
| Biosynthetic process |
2.98E-100 |
| Small molecule metabolic process |
6.52E-33 |
| Catabolic process |
1.71E-24 |
| Cellular lipid metabolic process |
6.40E-18 |
| Cellular protein metabolic process |
3.16E-16 |
| Glycosaminoglycan metabolic process |
2.98E-11 |
| Nucleobase-containing compound catabolic process |
2.42E-10 |
| Energy reserve metabolic process |
1.34E-09 |
| Chondroitin sulfate metabolic process |
1.78E-05 |
| Sulfur compound metabolic process |
9.17E-05 |
| mRNA metabolic process |
1.05E-04 |
| Hexose transport |
4.99E-04 |
| Vitamin metabolic process |
5.19E-04 |
| Generation of precursor metabolites and energy |
7.34E-04 |
| Water-soluble vitamin metabolic process |
1.12E-03 |
| DNA metabolic process |
1.17E-03 |
| Phospholipid metabolic process |
1.56E-03 |
| Glycerophospholipid biosynthetic process |
2.22E-03 |
| Nucleobase-containing small molecule metabolic process |
2.42E-03 |
| Regulation of glucose transport |
2.95E-03 |
| RNA metabolic process |
2.95E-03 |
| Glutamate secretion |
4.09E-03 |
| Regulation of insulin secretion |
5.07E-03 |
| Nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
5.94E-03 |
| Phosphatidylinositol biosynthetic process |
8.03E-03 |
| Inositol phosphate metabolic process |
1.04E-02 |
| Dolichol-linked oligosaccharide biosynthetic process |
1.50E-02 |
| Unsaturated fatty acid metabolic process |
3.08E-02 |
| Alpha-linolenic acid metabolic process |
3.08E-02 |
| Keratan sulfate metabolic process |
4.32E-02 |
| Regulation of cellular amino acid metabolic process |
4.69E-02 |
| Immune Function |
|
| Fc-epsilon receptor signaling pathway |
1.42E-37 |
| TRIF-dependent toll-like receptor signaling pathway |
5.92E-27 |
| Toll-like receptor 10 signaling pathway |
1.08E-22 |
| MyD88-independent toll-like receptor signaling pathway |
1.25E-22 |
| Toll-like receptor TLR1:TLR2 signaling pathway |
1.46E-22 |
| Toll-like receptor TLR6:TLR2 signaling pathway |
1.46E-22 |
| Fc-gamma receptor signaling pathway involved in phagocytosis |
2.37E-19 |
| Toll-like receptor 3 signaling pathway |
2.91E-19 |
| Toll-like receptor 5 signaling pathway |
1.40E-18 |
| Immune system process |
4.31E-18 |
| Toll-like receptor 9 signaling pathway |
1.07E-17 |
| Platelet activation |
1.34E-17 |
| Toll-like receptor 4 signaling pathway |
3.60E-15 |
| Toll-like receptor 2 signaling pathway |
3.85E-14 |
| Toll-like receptor signaling pathway |
2.50E-13 |
| MyD88-dependent toll-like receptor signaling pathway |
4.31E-09 |
| Platelet degranulation |
8.94E-09 |
| Leukocyte migration |
1.02E-08 |
| Innate immune response |
1.59E-07 |
| Antigen processing and presentation of exogenous peptide antigen via MHC class I |
2.46E-07 |
| Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
3.80E-07 |
| Antigen processing and presentation of exogenous peptide antigen via MHC class II |
2.19E-06 |
| Positive regulation of type I interferon production |
1.49E-05 |
| Negative regulation of type I interferon production |
1.56E-03 |
| Cytokine-mediated signaling pathway |
3.24E-03 |
| Antigen processing and presentation of peptide antigen via MHC class I |
1.25E-02 |
| Regulation of interferon-gamma-mediated signaling pathway |
1.90E-02 |
